Results 181 to 190 of about 1,132,735 (361)

Longitudinal metabolomics study of phosphate‐adenine‐guanosine‐glucose‐saline‐mannitol stored red blood cells

open access: yesTransfusion, EarlyView.
Abstract Background The storage of red blood cells (RBCs) is essential for transfusion but leads to storage lesions that compromise RBC quality and increase the risk of transfusion‐related adverse effects, including allergic transfusion reactions (ATRs). Understanding storage‐induced metabolic change is crucial for enhancing transfusion safety.
Gürkan Bal   +5 more
wiley   +1 more source

Association between ABO blood groups and rhesus antigen and susceptibility to COVID-19 in the Yazd hospital

open access: gold, 2021
Emad Behboudi   +7 more
openalex   +1 more source

Situating and repositioning disability within the blood donation context: Insights from 12 blood collection agencies

open access: yesTransfusion, EarlyView.
Abstract Background Diversity Equity and Inclusion initiatives in blood donation have progressed for priority groups such as ethnic minorities, men who have sex with men, and trans and diverse donors. However, advocacy for persons with disabilities (PWDs) in healthcare, especially in blood donation, remains slow.
Aaron Akpu Philip   +2 more
wiley   +1 more source

Exploring the immunomodulatory impacts of blood manufacturing consolidation

open access: yesTransfusion, EarlyView.
Abstract Introduction The immunomodulatory consequences of blood transfusion, known as transfusion‐related immune modulation (TRIM), are often not captured by hemovigilance systems. Changes to blood product manufacturing processes may impact patient outcomes.
Amanda Kauffman   +11 more
wiley   +1 more source

Association of ABO and RhD blood groups with the risk of HIV infection

open access: gold, 2023
Genevieve Jacobs   +5 more
openalex   +2 more sources

Gender‐neutral assessment in Australia: Acceptance and eligibility among current donors

open access: yesTransfusion, EarlyView.
Abstract Background Blood collection agencies are shifting to gender‐neutral risk assessment for donor eligibility. Pre‐implementation data on donor eligibility and acceptance rates are essential to understand the likely impact of these changes locally.
Barbara M. Masser   +5 more
wiley   +1 more source

ABO Blood Group and Bleeding Post-LVAD [PDF]

open access: bronze, 2016
Robert T. Cole   +10 more
openalex   +1 more source

Pathogen‐reduced plasma, cryoprecipitate reduced for therapeutic plasma exchange

open access: yesTransfusion, EarlyView.
Abstract Background Therapeutic plasma exchange (TPE) for thrombotic thrombocytopenic purpura (TTP) and auto‐immune disorders involves repeated patient exposure to allogenic plasma with the risk of transfusion‐transmitted infection (TTI).
Florian Tupin   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy